Charlene Jennifer Ong1, Jeffrey Gluckstein1, Osvaldo Laurido-Soto1, Yan Yan1, Rajat Dhar1, Jin-Moo Lee2. 1. From the Department of Neurology, Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School, Boston (C.J.O., J.G.); and Department of Neurology, Washington University School of Medicine, St. Louis, MO (O.L.-S., Y.Y., R.D., J.-M.L.). 2. From the Department of Neurology, Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School, Boston (C.J.O., J.G.); and Department of Neurology, Washington University School of Medicine, St. Louis, MO (O.L.-S., Y.Y., R.D., J.-M.L.). Leejm@wustl.edu.
Abstract
BACKGROUND AND PURPOSE: Rapid recognition of those at high risk for malignant edema after stroke would facilitate triage for monitoring and potential surgery. Admission data may be insufficient for accurate triage decisions. We developed a risk prediction score using clinical and radiographic variables within 24 hours of ictus to better predict potentially lethal malignant edema. METHODS: Patients admitted with diagnosis codes of cerebral edema and ischemic stroke, NIHSS score (National Institute of Health Stroke Score) of ≥8 and head computed tomographies within 24 hours of stroke onset were included. Primary outcome of potentially lethal malignant edema was defined as death with midline shift ≥5 mm or decompressive hemicraniectomy. We performed multivariate analyses on data available within 24 hours of ictus. Bootstrapping was used to internally validate the model, and a risk score was constructed from the results. RESULTS: Thirty-three percent of 222 patients developed potentially lethal malignant edema. The final model C statistic was 0.76 (confidence interval, 0.68-0.82) in the derivation cohort and 0.75 (confidence interval, 0.72-0.77) in the bootstrapping validation sample. The EDEMA score (Enhanced Detection of Edema in Malignant Anterior Circulation Stroke) was developed using the following independent predictors: basal cistern effacement (=3); glucose ≥150 (=2); no tPA (tissue-type plasminogen activator) or thrombectomy (=1), midline shift >0 to 3 (=1), 3 to 6 (=2), and 6 to 9 (=4); >9 (=7); and no previous stroke (=1). A score over 7 was associated with 93% positive predictive value. CONCLUSIONS: The EDEMA score identifies patients at high risk for potentially lethal malignant edema. Although it requires external validation, this scale could help expedite triage decisions in this patient population.
BACKGROUND AND PURPOSE: Rapid recognition of those at high risk for malignant edema after stroke would facilitate triage for monitoring and potential surgery. Admission data may be insufficient for accurate triage decisions. We developed a risk prediction score using clinical and radiographic variables within 24 hours of ictus to better predict potentially lethal malignant edema. METHODS:Patients admitted with diagnosis codes of cerebral edema and ischemic stroke, NIHSS score (National Institute of Health Stroke Score) of ≥8 and head computed tomographies within 24 hours of stroke onset were included. Primary outcome of potentially lethal malignant edema was defined as death with midline shift ≥5 mm or decompressive hemicraniectomy. We performed multivariate analyses on data available within 24 hours of ictus. Bootstrapping was used to internally validate the model, and a risk score was constructed from the results. RESULTS: Thirty-three percent of 222 patients developed potentially lethal malignant edema. The final model C statistic was 0.76 (confidence interval, 0.68-0.82) in the derivation cohort and 0.75 (confidence interval, 0.72-0.77) in the bootstrapping validation sample. The EDEMA score (Enhanced Detection of Edema in Malignant Anterior Circulation Stroke) was developed using the following independent predictors: basal cistern effacement (=3); glucose ≥150 (=2); no tPA (tissue-type plasminogen activator) or thrombectomy (=1), midline shift >0 to 3 (=1), 3 to 6 (=2), and 6 to 9 (=4); >9 (=7); and no previous stroke (=1). A score over 7 was associated with 93% positive predictive value. CONCLUSIONS: The EDEMA score identifies patients at high risk for potentially lethal malignant edema. Although it requires external validation, this scale could help expedite triage decisions in this patient population.
Authors: Christoph Beck; Anna Kruetzelmann; Nils D Forkert; Eric Juettler; Oliver C Singer; Martin Köhrmann; Jan F Kersten; Jan Sobesky; Christian Gerloff; Jens Fiehler; Peter D Schellinger; Joachim Röther; Götz Thomalla Journal: J Neurol Date: 2014-04-01 Impact factor: 4.849
Authors: Kevin N Sheth; W Taylor Kimberly; Jordan J Elm; Thomas A Kent; Albert J Yoo; Götz Thomalla; Bruce Campbell; Geoffrey A Donnan; Stephen M Davis; Gregory W Albers; Sven Jacobson; Gregory del Zoppo; J Marc Simard; Barney J Stern; Pitchaiah Mandava Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Götz Thomalla; Frank Hartmann; Eric Juettler; Oliver C Singer; Fritz-Georg Lehnhardt; Martin Köhrmann; Jan F Kersten; Anna Krützelmann; Marek C Humpich; Jan Sobesky; Christian Gerloff; Arno Villringer; Jens Fiehler; Tobias Neumann-Haefelin; Peter D Schellinger; Joachim Röther Journal: Ann Neurol Date: 2010-10 Impact factor: 10.422
Authors: David Asuzu; Karin Nyström; Anirudh Sreekrishnan; Joseph Schindler; Charles Wira; David Greer; Janet Halliday; W Taylor Kimberly; Kevin N Sheth Journal: Neurocrit Care Date: 2016-06 Impact factor: 3.210
Authors: Antonio Muscari; Luca Faccioli; Maria Vittoria Lega; Andrea Lorusso; Marco Pastore Trossello; Giovanni M Puddu; Luca Spinardi; Marco Zoli Journal: Neurol Sci Date: 2019-01-19 Impact factor: 3.307
Authors: Hossein Mohammadian Foroushani; Ali Hamzehloo; Atul Kumar; Yasheng Chen; Laura Heitsch; Agnieszka Slowik; Daniel Strbian; Jin-Moo Lee; Daniel S Marcus; Rajat Dhar Journal: Neurocrit Care Date: 2020-07-29 Impact factor: 3.210
Authors: Simiao Wu; Grant Mair; Geoff Cohen; Zoe Morris; Anders von Heijne; Nick Bradey; Lesley Cala; Andre Peeters; Andrew J Farrall; Alessandro Adami; Gillian Potter; Ming Liu; Richard I Lindley; Peter A G Sandercock; Joanna M Wardlaw Journal: Stroke Vasc Neurol Date: 2020-11-27